Picture of Eli Lilly and logo

LLY — Eli Lilly and News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Stipple Bio Enters Multi-Target Oncology Collaboration With Eli Lilly

BRIEF-Stipple Bio Enters Multi-Target Oncology Collaboration With Eli Lilly

- Eli Lilly and Company LLY.N:

  • STIPPLE BIO: ENTERS MULTI-TARGET ONCOLOGY COLLABORATION WITH ELI LILLY

  • STIPPLE BIO: WILL BE ELIGIBLE TO RECEIVE AGGREGATE PAYMENTS OF UP TO $5.9 BILLION DOLLARS UPON ACHIEVEMENT OF RESEARCH WITH LILLY

  • STIPPLE BIO: WILL RECEIVE AN UPFRONT PAYMENT AND AN EQUITY INVESTMENT UNDER TERMS OF LILLY AGREEMENT

  • STIPPLE BIO: LILLY RECEIVES EXCLUSIVE WORLDWIDE RIGHTS TO DEVELOP AND COMMERCIALIZE PRODUCTS ARISING FROM COLLABORATION

Source text: ID:nGNX8nZBX6

Further company coverage: LLY.N


((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Eli Lilly and

See all news